Australian cancer treatment provider Icon Group said it expects its biggest investor, private equity firm Quadrant, to sell its 55 percent stake in an initial public offering by mid-2017, and said Icon is now worth A$1 billion ($745 million) in total.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
